- In January 2022, Cardiovascular Systems, Inc., in collaboration with OrbusNeich Medical Company Ltd, received approval from the United States Food and Drug Administration (FDA) for the Scoreflex NC Scoring Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheter. This device is designed to enhance coronary artery treatment by improving the success of balloon angioplasty procedures, offering better clinical outcomes
- In January 2022, Humacyte announced the preclinical results for its Small-Diameter Human Acellular Vessel (HAV) in Coronary Artery Bypass Grafting (CABG). The HAV aims to provide an innovative solution for vascular replacement, demonstrating promising results in terms of biocompatibility and long-term effectiveness in coronary artery surgeries, thus advancing cardiovascular surgery and treatment options
- In February 2020, Mexico joined the HEARTS initiative, a program led by the Pan American Health Organization (PAHO) and the World Health Organization (WHO), to enhance primary healthcare for cardiovascular diseases (CVD). The initiative focuses on improving the prevention and management of hypertension at the primary care level, strengthening healthcare systems and reducing CVD-related morbidity and mortality
